(Q44550880)

4 December 2017

Incidence and risk factors for nevirapine-associated rash (English)

1 reference

4 December 2017

8

Jos H Beijnen

1 reference

4 December 2017

6

Eric C M van Gorp

1 reference

4 December 2017

7

Alwin D R Huitema

1 reference

4 December 2017

Monique M R de Maat

1

1 reference

4 December 2017

Rob ter Heine

2

1 reference

4 December 2017

Jan W Mulder

3

1 reference

4 December 2017

Pieter L Meenhorst

4

1 reference

4 December 2017

Albert T A Mairuhu

5

1 reference

4 December 2017

12 August 2003

1 reference

European Journal of Clinical Pharmacology

4 December 2017

1 reference

4 December 2017

59

1 reference

4 December 2017

5-6

1 reference

4 December 2017

457-462

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-003-0613-3

4 December 2017

0 references

cites work

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

12 December 2020

Experience with nevirapine in previously treated HIV-1-infected individuals

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Sex differences in nevirapine rash

1 reference

12 December 2020

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

1 reference

12 December 2020

Adverse effects of antiretroviral therapy

1 reference

12 December 2020

1 reference

12 December 2020

A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease

1 reference

12 December 2020

Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.

1 reference

12 December 2020

Prevention of nevirapine-associated rash

1 reference

12 December 2020

Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

12 December 2020

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

1 reference

12 December 2020

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P

1 reference

12 December 2020

The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression

1 reference

12 December 2020

High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication

1 reference

12 December 2020

Nevirapine-associated Stevens-Johnson syndrome

1 reference

12 December 2020

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

1 reference

12 December 2020

A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group.

1 reference

12 December 2020

Disposition and biotransformation of the antiretroviral drug nevirapine in humans.

1 reference

12 December 2020

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

1 reference

12 December 2020

Cutaneous disease and drug reactions in HIV infection

1 reference

12 December 2020

Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 study

1 reference

12 December 2020

10.1007/S00228-003-0613-3

Identifiers

DOI

1 reference

release_ysr5stera5e4bel7tkuwsbyzfe

4 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ysr5stera5e4bel7tkuwsbyzfe

24 November 2022

mapped directly with Wikidata item

1 reference